US Patent Issued to The Regents of the University of California on Nov. 18 for "Gene targets for T-cell-based immunotherapy" (California Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,533, issued on Nov. 18, was assigned to The Regents of the University of California (Oakland, Calif.).

"Gene targets for T-cell-based immunotherapy" was invented by Alexander Marson (Oakland, Calif.), Eric Shifrut (Oakland, Calif.), Julia Carnevale (Oakland, Calif.) and Alan Ashworth (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are genetically modified T cells that exhibit increased proliferation compared to wild-type T cells when stimulated, methods of generating such T cells, and methods of using the T cells for the treatment of a disease such as cancer."

The patent was filed on July 9, 2019, under Application N...